Evidence map›Paper›PMID 35801409›Full record

ArticleAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica2022

Vaginal microbiome following orally administered probiotic.

Frederik Boetius Hertz, Jacob Bak Holm, Albert Pallejá, María Kristín Björnsdóttir, Lasse Sommer Mikkelsen, Erik Brandsborg, Niels Frimodt-Møller

Open access · hybridAbstract read
In one paragraph

Article in APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Microbiology spectrum · 2025
    Trial
  3. Nutrients · 2025
    Trial
  4. Review
  5. Microorganisms · 2026
    Article
  6. Orally ingestedFrontiers in microbiology · 2026
    Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Frederik Boetius HertzDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Jacob Bak HolmClinical Microbiomics A/S, Copenhagen, Denmark.
Albert PallejáClinical Microbiomics A/S, Copenhagen, Denmark.
María Kristín BjörnsdóttirDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Lasse Sommer MikkelsenDeerland Probiotics & Enzymes A/S, Hundested, Denmark.
Erik BrandsborgDeerland Probiotics & Enzymes A/S, Hundested, Denmark.
Niels Frimodt-MøllerDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Clinical Microbiomics (Denmark) · DKNovozymes (Denmark) · DKRigshospitalet · DKSlagelse Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we present a longitudinal shotgun sequencing metagenomics study of 16 healthy, Danish women in the reproductive age. The aim of the study was to investigate whether lactobacilli, orally consumed, had any impact on the vaginal microbiome and its functional potential. The 16 women aged 19-45 years were recruited from Copenhagen, Denmark. One baseline vaginal sample (Day 0) and two study samples (Days 25-30 and Days 55-60, respectively), were sampled. The vaginal samples were analyzed by shotgun metagenomics. We detected 26 species in the vaginal microbiota of the 16 women, of which six belonged to the Lactobacillus genus. We observed three vaginal microbiome clusters mainly dominated by Gardnerella vaginalis, Lactobacillus iners, or Lactobacillus crispatus. The oral probiotic had no detectable effect on either the composition or the functional potential of the vaginal microbiota. Most of the study subjects (11 out of 16 women) exhibited only minor changes in the vaginal microbiome during the treatment with probiotics. Any compositional changes could not be associated to the probiotic treatment. Future studies may benefit from an increased number of participants, and administration of the probiotics during conditions with bacterial imbalance (e.g., during/after antibiotic treatment) or the use of different Lactobacillus spp. known to colonize the vagina.

Indexed as

MicrobiotaProbioticsVaginosis, BacterialFemaleGardnerella vaginalisHumansVaginahealthy microbiomepublic healthshotgun metagenomicsVaginal microbiomewomen

Identifiers

PMID35801409
PMCPMC9540456
OpenAlexW4284895763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.